| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 24,416 | 23,605 | 22,564 | 30,471 | | Cost of Revenue | 8,473 | 8,215 | 7,876 | 11,152 | | | Gross Profit | 15,943 | 15,390 | 14,688 | 19,319 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,434 | 10,701 | 11,450 | 12,923 | | Non Recurring |
-
|
-
|
-
| 62,483 | | Others | 672 | 725 | 731 | 736 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,838 | 3,964 | 2,507 | (56,823) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 90 | 113 | (476) | (149) | | Earnings Before Interest And Taxes | 5,928 | 4,078 | 2,031 | (56,972) | | Interest Expense | 2,733 | 2,780 | 2,016 | 2,111 | | Income Before Tax | 3,195 | 1,298 | 15 | (59,083) | | Income Tax Expense | 1,815 | 589 | 7 | (22,619) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 866 | 709 | 8 | (36,464) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,379 | 709 | 8 | (36,464) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,379 | $709 | $8 | ($36,464) |
|
0.11% Nasdaq 
0.01%
Income Statement
